세계의 신종 코로나바이러스 감염증(COVID-19) 관련 제품 및 서비스 시장 예측(-2024년)

COVID-19 Mitigation Products (PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, and More) Market Research to 2024

US $ 5,950 ￦ 7,599,000

PDF (Single User License)

US $ 6,950 ￦ 8,876,000

PDF (Departmental License)

US $ 8,950 ￦ 11,430,000

PDF (Site License)

US $ 12,000 ￦ 15,326,000

PDF (Corporate License)

한글목차

세계적인 팬데믹을 배경으로 새로운 시장인 신종 코로나바이러스 감염증(COVID-19) 팬데믹 관련 제품 및 서비스 시장이 등장하고 있습니다. 시나리오에 의하면 2020-2024년 누적 시장 규모는 1조 6,000억 달러(낙관적 시나리오)와 2조 2,000억 달러(보수적 시나리오)가 될 것으로 예상됩니다.

팬데믹의 향후는 예측할 수 없기 때문에 본 보고서에는 2개의 시나리오가 포함되어 있습니다.

• 낙관적 시나리오 : 2021년 7월까지 집단 예방 접종이 시작될 것으로 상정
• 보수적 시나리오 : 2024년 7월까지 집단 예방 접종은 이용할 수 없을 것으로 상정

세계의 신종 코로나바이러스 감염증(COVID-19) 관련 제품 및 서비스 시장에 대해 조사 분석했으며, COVID-19의 개요, 관련 제품/서비스 시장, 업종별 시장, 지역별 시장, 국가별 시장 등에 대한 체계적인 정보를 제공합니다.

목차

COVID-19 팬데믹 관련 제품 시장 : 제1권

제1장 시장 정의

제2장 주요 요약

제3장 COVID-19(SARS-CoV-2) 팬데믹

제4장 시장 성장 촉진요인

제5장 시장 성장 저해요인

제6장 시장 SWOT 분석

제7장 비지니스 기회와 과제

제8장 COVID-19 팬데믹 관련 업계

제9장 COVID-19 팬데믹 관련 제품 업계 : Five Forces 분석

세계 시장

제10장 세계의 COVID-19 팬데믹 관련 시장

COVID-19 팬데믹 관련 제품 시장 : 제2권

제품/서비스 시장

제1장 COVID-19 백신 시장

제2장 COVID-19 감염 후 치료제 시장

제3장 기타 제약 업계 제품 - COVID-19 팬데믹 관련 시장

제4장 PCR 검사 장비·소프트웨어 - COVID-19 팬데믹 관련 시장

제5장 로봇 PCR 검사 시스템·소프트웨어 - COVID-19 팬데믹 관련 시장

제6장 PCR 시약·소모품 - COVID-19 팬데믹 관련 시장

제7장 코·입용 스왑 - COVID-19 팬데믹 관련 시장

제8장 자기 회수 PCR 검사 키트 - COVID-19 팬데믹 관련 시장

제9장 혈청 검사 키트 - COVID-19 팬데믹 관련 시장

제10장 스탠드오프형 체온계 - COVID-19 팬데믹 관련 시장

제11장 X선 검사 - COVID-19 팬데믹 관련 시장

제12장 CT 검사 - COVID-19 팬데믹 관련 시장

제13장 초음파 검사 - COVID-19 팬데믹 관련 시장

제14장 FDG-PET/CT 검사·폐수 검사 - COVID-19 팬데믹 관련 시장

제15장 PACS·원격방사선 - COVID-19 팬데믹 관련 시장

제16장 PPE 가운 - COVID-19 팬데믹 관련 시장

제17장 장갑 - COVID-19 팬데믹 관련 시장

제18장 페이스 마스크 - COVID-19 팬데믹 관련 시장

제19장 의료용 페이스 실드 - COVID-19 팬데믹 관련 시장

제20장 눈 보호 - COVID-19 팬데믹 관련 시장

제21장 PPE 멸균 : 시스템·소모품 - COVID-19 팬데믹 관련 시장

제22장 손·표면 소독제 - COVID-19 팬데믹 관련 시장

제23장 제염 - COVID-19 팬데믹 관련 시장

제24장 기타 개인용 방호구 - COVID-19 팬데믹 관련 시장

제25장 AI·빅데이터·딥러닝 - COVID-19 팬데믹 관련 시장

제26장 재택 의료 IT - COVID-19 팬데믹 관련 시장

제27장 지리 감시 시스템·서비스 - COVID-19 팬데믹 관련 시장

제28장 E-Health - COVID-19 팬데믹 관련 시장

제29장 블록체인 기술 - COVID-19 팬데믹 관련 시장

제30장 기타 ICT - COVID-19 팬데믹 관련 시장

제31장 비침습적 인공호흡기 - COVID-19 팬데믹 관련 시장

제32장 침습적 인공호흡기 - COVID-19 팬데믹 관련 시장

제33장 차세대 인공호흡기 - COVID-19 팬데믹 관련 시장

제34장 재택 "ICU"(장비·소프트웨어·서비스) - COVID-19 팬데믹 관련 시장

제35장 긴급 대응 병원 - COVID-19 팬데믹 관련 시장

제36장 신장 투석 - COVID-19 팬데믹 관련 시장

제37장 ECMO 대응 - COVID-19 팬데믹 관련 시장

제38장 기타 집중 치료 모달리티 - COVID-19 팬데믹 관련 시장

제39장 가운 제조 공장 - COVID-19 팬데믹 관련 시장

제40장 장갑 제조 공장 - COVID-19 팬데믹 관련 시장

제41장 페이스 마스크 제조 공장 - COVID-19 팬데믹 관련 시장

제42장 페이스 실드 제조 공장 - COVID-19 팬데믹 관련 시장

제43장 혈청 검사 키트 제조 공장 - COVID-19 팬데믹 관련 시장

제44장 멜트블로운 PPE 패브릭 제조 공장 - COVID-19 팬데믹 관련 시장

제45장 스펀본드 PPE 패브릭 제조 공장 - COVID-19 팬데믹 관련 시장

제46장 자기 회수 PCR 검사 키트 제조 공장 - COVID-19 팬데믹 관련 시장

제47장 인공호흡기 제조 공장 - COVID-19 팬데믹 관련 시장

제48장 PCR 시약 제조 공장 - COVID-19 팬데믹 관련 시장

제49장 PCR 검사 시스템 제조 공장 - COVID-19 팬데믹 관련 시장

제50장 코·입용 스왑 제조 공장 - COVID-19 팬데믹 관련 시장

제51장 의료용 유리·기타 제조 공장 - COVID-19 팬데믹 관련 시장

제52장 R&D 장비·소모품 - COVID-19 팬데믹 관련 시장

제53장 의료용 유리·기타 제품·서비스 - COVID-19 팬데믹 관련 시장

COVID-19 팬데믹 관련 제품 시장 : 제3권

업종별 시장

제1장 병원·외과 병원 - COVID-19 팬데믹 관련 시장

제2장 임상 검사실 - COVID-19 팬데믹 관련 시장

제3장 클리닉 - COVID-19 팬데믹 관련 시장

제4장 응급의료서비스(EMS) - COVID-19 팬데믹 관련 시장

제5장 재택 케어·요양원 - COVID-19 팬데믹 관련 시장

제6장 연구기관 - COVID-19 팬데믹 관련 시장

지역별 시장

제7장 북미 - COVID-19 팬데믹 관련 시장

제8장 유럽 - COVID-19 팬데믹 관련 시장

제9장 아시아태평양 - COVID-19 팬데믹 관련 시장

제10장 중동·아프리카·라틴아메리카 - COVID-19 팬데믹 관련 시장

국가별 시장

제11장 미국 - COVID-19 팬데믹 관련 시장

제12장 캐나다 - COVID-19 팬데믹 관련 시장

제13장 영국 - COVID-19 팬데믹 관련 시장

제14장 독일 - COVID-19 팬데믹 관련 시장

제15장 프랑스 - COVID-19 팬데믹 관련 시장

제16장 이탈리아 - COVID-19 팬데믹 관련 시장

제17장 기타 유럽 - COVID-19 팬데믹 관련 시장

제18장 인도 - COVID-19 팬데믹 관련 시장

제19장 중국 - COVID-19 팬데믹 관련 시장

제20장 한국 - COVID-19 팬데믹 관련 시장

제21장 일본 - COVID-19 팬데믹 관련 시장

제22장 기타 아시아태평양 - COVID-19 팬데믹 관련 시장

제23장 세계의 기타 지역 - COVID-19 팬데믹 관련 시장

COVID-19 팬데믹 관련 제품 시장 : 제4권

부록

제1장 부록 1 : 일반적인 인플루엔자와 코로나바이러스의 차이와 유사점

제2장 부록 2 : 의료 종사자용 코로나바이러스용 PPE

제3장 부록 3 : 눈 보호 - CDC 공급 최적화 전략

제4장 부록 4 : 절연 가운 - CDC 공급 최적화 전략

제5장 부록 5 : 페이스 마스크 - CDC 공급 최적화 전략

제6장 부록 6 : N95 인공호흡기 - CDC 공급 최적화 전략

제7장 부록 7 : CDC 성인용 백신 가격표

제8장 부록 8 : CDC COVID-19 바이오 세이프티 가이드라인

제9장 부록 9 : 2020 Global Desperation to Protect Medical Workers

제10장 부록 10 : COVID-19에 대응한 소독 절차

제11장 부록 11 : COVID-19 USA Medical Services Stimulus April 2020

제12장 부록 12 : 신흥 유행병에 대한 유럽의 대응

제13장 부록 13 : COVID-19 진단 검사 - CDC·FDA에 의한 개발과 규제

제14장 부록 14 : The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

제15장 부록 15 : The Global Research Collaboration for Infectious Disease Preparedness(GLOPID-R)

제16장 부록 16 : COVID-19 임상 데이터 비교(국가별)

제17장 부록 17 : 재택 의료용 IT

제18장 부록 18 : PCR 검사와 항체 검사의 차이

제19장 부록 19 : COVID-19 팬데믹 - 세계 경제에 대한 영향

제20장 부록 20 : COVID-19 검사

제21장 부록 21 : WHO 유럽 지역에서 GeneXpert 플랫폼의 역할

제22장 부록 22 : 약어

제23장 부록 23 : 용어집

제24장 부록 24 : 참고문헌

제25장 조사 방법

제26장 면책사항과 저작권

KSM 20.09.07

영문 목차

영문목차

Title:
COVID-19 Mitigation Products
(PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, AI, Personal Protection Gear, Teleradiology, Eye Protection, Ultrasound, Dialysis, CT, X-Ray, Blockchain Technologies, Medical Glass, Telemedicine, Face Shields, Gowns, Homecare, Gloves, E-Health, Robotic PCR, Antigen Test, Monoclonal Antibody, Face Masks, Therapeutic Drugs, ICU, PACS, PPE Sterilization and More) Market Research, to 2024.

On the backdrop of the global pandemic, a need for essential pandemic mitigation products and services emerged a new market, the COVID-19 Pandemic Mitigation Products Market.

"the COVID-19 Mitigation Products Market is a Seller's Market.....This does not happen Very Often"

To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:

• 1. Optimistic scenario - assumes (among other things) that mass vaccination will commence by July 2021

• 2. Conservative scenario - assumes (among other things) that no mass vaccination will be available until July 2024

According to the report scenarios, the cumulative 2020-2024 market* size is expected to be $1.6 Trillion (scenario A, the optimistic one) and $2.2 Trillion (scenario B, conservative).

Market revenue is forecasted to reach at 2020-2024: $1.6 Trillion (scenario A); $2.2 Trillion (senario B)

(^*) Market size is year and scenario dependent.

Why trust this report?

• The team which created this report was led by ex-executives of the medical industry and bio-security experts

• The team has published since 2006, 36 Pandemic related market reports

• Team members managed since 1974 medical industry companies, sales & marketing, and R&D departments

• As the COVID-19 pandemic knowledge changes all the time, we update the report once a month

Bottom Line: While other COVID-19 market reports are written (at best) by MBAs, this report is published by seasoned professionals for industry executives.

"It's your worst nightmare, the perfect storm. .....when I say unprecedented, I mean dating back to the 1818 historic pandemic..... I think 50 years from now, people are going to be reflecting historically on this, the we used to reflect on the 1918 outbreak." Anthony Fauci, National Institute of Allergy and Infectious Diseases director, July 2020.

As we write this report, billions, the largest part of the globe's populace, are restricted to their homes or subject to social distancing, in an effort to contain one of the most terrible plagues of modern times. Trade and industry activity has dropped, millions are out of work, and whole industries have ground to a halt.

Quite understandably, a couple of issues are on your mind:

• How can my company help out in the global endeavor to mitigate the pandemic?

• Do this crisis open new business opportunities to my organization?

• How will I know which opportunities are best to my company?

The intention of this report is to give you the answers to these questions!

The COVID-19 pandemic exposed acute deficiencies of many essential products and services, from PPE & ventilators to surge ICUs and homecare equipment, from PCR reagents to digital contact tracing systems. Never before has world leading healthcare communities been faced with the likelihood of having to ration or function without critical medical supplies and services on this magnitude.

In the beginning, it took 62 days for COVID-19 to infect 10,000 people.... On July 23^rd it took only 55 minutes to infect 10,000. A growth rate of 1,653% ! No wonder trillions will be invested to save people and the economy.

COVID-19 Pandemic Mitigation Products & Services Market Segmentation Vectors

5 Regions, 13 National Markets, 6 Vertical Markets,
and 4 Revenue Source Markets:

54 Products and Services Markets:

The ‘COVID-19 Mitigation Products Market Research’ presents a thorough market analysis of 54 products & services, 6 end user, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.

This 1035-page 5-volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today's strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market. The report includes the industry value chain, SWOT analysis, market drives & inhibitors, business opportunities, barriers to entry, supplier power, buyer power and barriers to substitution.

The 2024 COVID-19 Pandemic Mitigation
Products Market (Scenario A), by Region

Why Buy this Homeland Security Market Report?

A. Questions answered in this report include:

• What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecast trends during 2020-2024?

• What are the most attractive business opportunities?

• What drives the customers to purchase solutions and services?

• What are the COVID-19 Mitigation technology & services trends?

• What is the 212 sub-markets size over the 2020-2024 period?

• What are the challenges to market penetration & growth?

B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.

With a highly fragmented market we address the "money trail" - each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

By 54 Products and Services:

By 6 End User Markets:

• 1. Hospitals and Surge Hospitals
• 2. Clinical Labs
• 3. Clinics
• 4. Emergency Medical Services (EMS)
• 5. Homecare & Nursing Homes
• 6. Research Bodies

By 13 National Markets:

By 5 Regional Markets:

• 1. North America
• 2. Latin America
• 3. Europe
• 4. Middle East & Africa
• 5. Asia PacifiC

By 4 Revenue Source Markets:

• 1. Product Sales
• 2. Training Services
• 3. Planning & Consulting
• 4. Maintenance & Upgrade

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

• 1. Market drivers & inhibitors
• 2. Business opportunities
• 3. SWOT analysis

Competitive analysis for each of the 54 products and services that covers:

• 1. Barriers to Entry
• 2. Supplier Power
• 3. Buyer Power
• 4. Barriers to Substitution.
• 5. Business environment
• 6. The 2020-2024 market segmented into 212 submarkets

D. The report provides an updated extensive data of the leading 37 companies (including companies' profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).

E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources

F. The report mentions > 450 Vendors including the following:

3M Company, 3Scan, Abbott , AbCellera, Advenio Technosys, Agfa Healthcare, Agilent Technologies, AiCure, Aindra, Allscripts Healthcare Solutions, Amara Health Analytics , Amazon , analyticsMD, Apixio, Apple, Arterys Inc, Atlas Wearables, Atomwise, Avalon Nutrition VITL, Babylon Health, Bay Labs, Behold.ai, benevolent.ai, BIOBEATS, BlueDot, Bollé Safety, Bullard, Buoy Health, Care Angel Wearables QorQL, Careskore, Clinithink, Cloud Pharmaceuticals, CloudMedx, CureMetrix Mental health Ginger.io, Cyrcadia, Deep 6 AI, Deep Genomics, Dell Technologies Inc., Delta Plus Group, Desktop Genetics Virtual mate Ada Health, DreaMed Diabetes, Dupont, EaglEyeMed, Eli Lilly, Encon Safety Products, Enlitic, EnsoData, Entopsis, Envisagenics Research iCarbonX, ERB Industries Inc., Ergodyne, Essilor of America, Flashback Technologies, Flow Health, Ford, Freenome, Frequency Therapeutics Inc., Fujifilm Holdings Corporation, Gateway Safety Inc., GE Healthcare, General Electric, General Motors, General Vision, Gentex Corporation, Gibco, Gilead Sciences, Globavir Biosciences, Google, Healint, Health Fidelity, HealthNextGen, HexArmor, Hindsait, Honeywell Safety Products, IBM, Imagen Technologies, Imagia Cybernetics, Infermedica, Infervision, Inovio Pharmaceuticals, Inside DNA, InSilico Medicine, Intel Corporation, Intendu, Invitrogen, Ion Torrent, Ironwear, Johnson & Johnson (Janssen), Jvion, Kapa Biosystems, Keen Eye Technologies, Kimberly-Clark Professional, Koninklijke Philips NV, Lexmark International Inc., LifeGraph, Lucina Health, Lumiata, Lunit, Lytics, Magnea, Maxim Biotech, Maxwell MRI, McKesson Corporation, MCR Safety, Medal, Medalogix, Medasense, MedAware, Medtronic, MedWhat, MedyMatch , Merck, Metabiota, Micron Technology, Microsoft Corporation, Mindshare Medical, Moderna, Morpheo, Niramai Health Analytix, Novarad Corporation, NuMedii, Numerate, Nuritas Pharma Turbine, Nvidia Corporation, Oncora Medical, Ovuline, PeerWell, Pfizer, Philips, Philips Healthcare, PhysIQ., Precision Health Intelligence, Predible Health, Profility, Proscia, pulseData, Pyramex Safety, Qualaris Healthcare Solutions, Qualcomm Incorporated, Qualcomm Incorporated, Qure. Ai, Radians Inc., Recursion Pharmaceuticals, Regeneron Pharmaceuticals, Roam Analytics , Roche, RxPREDICT, Safety Optical Service, Samsung Electronics Co., Ltd, Sanofi, Saykara, Sellstrom Manufacturing Company (SureWerx), Sense.ly, Sensory Inc., Siemens, Sigma-Aldrich Corp., Skymind Inc., Thermo Fisher Scientific, Toshiba, Vir Biotechnology Inc., VisionAid Inc., WuXi Biologics, Xilinx Inc..

G. COVID-19 Pandemic Mitigation Products & Services Market report includes 24 appendices:

• 1. Appendix 1: Differences & Similarities Between Common Flu and Coronavirus

• 2. Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel

• 3. Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection

• 4. Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns

• 5. Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks

• 6. Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

• 7. Appendix 7: CDC Adult Vaccine Price List

• 8. Appendix 8: The CDC COVID-19 Bio-Safety Guidelines

• 9. Appendix 9: The 2020 Global Desperation to Protect Medical Workers

• 10. Appendix 10: Disinfection Procedures for COVID-19

• 11. Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020

• 12. Appendix 12: European Preparedness Against Emerging Epidemics

• 13. Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19

• 14. Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

• 15. Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)

• 16. Appendix 16: Comparing Clinical COVID-19 Data by Nation

• 17. Appendix 17: Home Healthcare IT

• 18. Appendix 18: The Difference between PCR and Antibody Tests

• 19. Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021

• 20. Appendix 20: COVID-19 Tests

• 21. Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region

• 22. Appendix 22: Abbreviations

• 23. Appendix 23: Glossary

• 24. Appendix 24: Bibliography

COVID-19 pandemic mitigation market research team

The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen identification, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, ultrasound, electron microscopy, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.

As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products and services industries. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies. The team published six months later a set of 32 Coronavirus mitigation market reports.

Table of Contents

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 1

1. Market Definition

• 1.1. Introduction
• 1.2. Scenario A: Assumptions
• 1.3. Scenario B: Assumptions

2. Executive Summary

• 2.1. Key Findings
• 2.2. COVID-19 Mitigation Funding (January - May 2020)
• 2.3. Key Conclusions
• 2.4. COVID-19 Pandemic Mitigation Products Market Research Vectors
• 2.5. COVID-19 Pandemic Mitigation R&D Challenges
• 2.6. Global COVID-19 Pandemic Mitigation Market - 2020-2024
  • 2.6.1. Products & Services Groups Markets
  • 2.6.2. Products & Services Markets
  • 2.6.3. Vertical Markets
  • 2.6.4. Revenue Source Markets
  • 2.6.5. Regional Markets
  • 2.6.6. National Markets

3. The SARS CoV 2 2019 Pandemic

• 3.1. COVID-19 Basics
• 3.2. COVID-19 Infection Rate
• 3.3. Social Distancing
• 3.4. The Effect of Quarantine
• 3.5. Comparison of SARS-CoV-2 and Common Cold and Flu Viruses
• 3.6. The SARS-CoV-2 Genome Information
• 3.7. Active Infection Testing
  • 3.7.1. Nucleic Acid Detection
  • 3.7.2. Antigen Detection
  • 3.7.3. Other Technologies
• 3.8. Serology Testing

4. Market Drivers

5. Market Inhibitors

• 6. COVID-19 Pandemic Mitigation Products Market SWOT Analysis
• 6.1. Strengths
• 6.2. Weaknesses
• 6.3. Opportunities
• 6.4. Threats

7. Business Opportunities & Challenges

8. COVID-19 Pandemic Mitigation Industry

• 8.1. The COVID-19 Pandemic Mitigation Products Value Chain
• 8.2. COVID-19 Pandemic Mitigation Products Industry Primary Activities
• 8.3. COVID-19 Pandemic Mitigation Products industry Support Activities

9. COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution

GLOBAL MARKET

10. Global COVID-19 Pandemic Mitigation Market - 2020-2024

• 10.1. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets - 2020-2024
  • 10.1.1. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario A
    • 10.1.1.1. Market Size
    • 10.1.1.2. Market Dynamics
    • 10.1.1.3. Market Share
  • 10.1.2. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario B
    • 10.1.2.1. Market Size
    • 10.1.2.2. Market Dynamics
    • 10.1.2.3. Market Share
  • 10.1.3. Global COVID-19 Pandemic Mitigation Market: Scenarios Comparison
• 10.2. Global COVID-19 Pandemic Mitigation Products & Services Markets - 2020-2024
  • 10.2.1. Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario A
    • 10.2.1.1. Market Size
    • 10.2.1.2. Market Dynamics
  • 10.2.2. Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario B
    • 10.2.2.1. Market Size
    • 10.2.2.2. Market Dynamics
  • 10.2.3. Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenarios Comparison
• 10.3. Global Vertical COVID-19 Pandemic Mitigation Markets - 2020-2024
  • 10.3.1. Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario A
    • 10.3.1.1. Market Size
    • 10.3.1.2. Market Dynamics
    • 10.3.1.3. Market Share
  • 10.3.2. Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario B
    • 10.3.2.1. Market Size
    • 10.3.2.2. Market Dynamics
    • 10.3.2.3. Market Share
  • 10.3.3. Global COVID-19 Pandemic Mitigation Vertical Markets: Scenarios Comparison
• 10.4. Global COVID-19 Pandemic Mitigation Products & Services Market by Revenue Source - 2020-2024
  • 10.4.1. Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
  • 10.4.2. Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario B
  • 10.4.3. Global COVID-19 Pandemic Mitigation Revenue Sources: Scenarios Comparison
• 10.5. Regional COVID-19 Pandemic Mitigation Markets - 2020-2024
  • 10.5.1. Regional COVID-19 Pandemic Mitigation Market: Scenario A
    • 10.5.1.1. Market Size
    • 10.5.1.2. Market Dynamics
    • 10.5.1.3. Market Share
  • 10.5.2. Regional COVID-19 Pandemic Mitigation Market: Scenario B
    • 10.5.2.1. Market Size
    • 10.5.2.2. Market Dynamics
    • 10.5.2.3. Market Share
  • 10.5.3. Regional COVID-19 Pandemic Mitigation Market: Scenarios Comparison
• 10.6. National COVID-19 Pandemic Mitigation Markets - 2020-2024
  • 10.6.1. National COVID-19 Pandemic Mitigation Market: Scenario A
    • 10.6.1.1. Market Size
    • 10.6.1.2. Market Dynamics
    • 10.6.1.3. Market Shares
  • 10.6.2. National COVID-19 Pandemic Mitigation Market: Scenario B
    • 10.6.2.1. Market Size
    • 10.6.2.2. Market Dynamics
    • 10.6.2.3. Market Share
  • 10.6.3. COVID-19 National Markets: Scenarios Comparison

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 2

PRODUCT/SERVICE MARKETS

1. COVID-19 Vaccines Market - 2020-2024

• 1.1. COVID-19 Vaccines Market Background
  • 1.1.1. Introduction
  • 1.1.2. Global COVID-19 Vaccine Development Funding
  • 1.1.3. Vaccines Prices
  • 1.1.4. COVID-19 Vaccines Market: Conclusions
  • 1.1.5. COVID-19 Vaccines:Business Opportunities
  • 1.1.6. COVID-19 Vaccines: Competitive Analysis: : Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 1.1.7. Present and Potential Vendors
• 1.2. Global COVID-19 Pandemic Mitigation: Vaccines Market - 2020-2024
  • 1.2.1. Vaccines COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 1.2.2. Vaccines COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

2. COVID-19 Post-Infection Therapeutic Drugs Market - 2020-2024

• 2.1. COVID-19 Post-Infection Therapies Drugs Market Background
  • 2.1.1. Introduction
  • 2.1.2. Computer Aided COVID-19 Drug Research
  • 2.1.3. Adaptive Designs For COVID 19 Clinical Trials
  • 2.1.4. COVID-19 Therapeutic Drugs Market: Conclusions
  • 2.1.5. COVID-19 Therapeutic Drug :Business Opportunities
  • 2.1.6. COVID-19 Post-Infection Therapeutic Drug: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 2.1.7. Present and Potential Vendors
• 2.2. Global COVID-19 Post-Infection Therapeutic Drugs Market - 2020-2024
  • 2.2.1. COVID-19 Post Infection Therapeutic Drugs Market - 2020-2024: Scenario A
  • 2.2.2. Therapeutic Drugs COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

3. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024

• 3.1. Other COVID-19 Pharma Industry Products Market Background
  • 3.1.1. Introduction and Findings
  • 3.1.2. Other COVID-19 Pharma Industry Products Market: Conclusions
  • 3.1.3. Other COVID-19 Pharma Industry Products: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
• 3.2. Global COVID-19 Pandemic Mitigation: Other Pharma Industry Products Market - 2020-2024
  • 3.2.1. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 3.2.2. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

4. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024

• 4.1. COVID-19 PCR Instrumentation & Software Market Background
  • 4.1.1. Introduction
  • 4.1.2. PCR Technologies & Procedures
  • 4.1.3. PCR Advantages
  • 4.1.4. PCR Limitations
  • 4.1.5. PCR Based Coronavirus Diagnostics Used and Developed During January - April 2020
  • 4.1.6. Efforts to Develop and Disseminate a Test for COVID-19
  • 4.1.7. PCR Purchasing Considerations
  • 4.1.8. Costs of PCR Testing
  • 4.1.9. PCR Instrumentation & Software Market: Conclusions
  • 4.1.10. PCR Instrumentation & Software: Business Opportunities
  • 4.1.11. PCR Instrumentation & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 4.1.12. Key Vendors
• 4.2. Global COVID-19 Pandemic Mitigation: PCR Instrumentation & Software Market - 2020-2024
  • 4.2.1. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 4.2.2. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

5. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024

• 5.1. COVID-19 Robotic PCR Systems & Software Market Background
  • 5.1.1. Introduction and Findings
  • 5.1.2. Pooling PCR Method Testing Over 60 Samples Simultaneously
  • 5.1.3. Robotic PCR Systems & Software Market: Conclusions
  • 5.1.4. Robotic PCR Systems & Software: Business Opportunities
  • 5.1.5. Robotic PCR Systems & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
• 5.2. Global COVID-19 Pandemic Mitigation: Robotic PCR Systems & Software Market - 2020-2024
  • 5.2.1. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 5.2.2. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

6. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

• 6.1. COVID-19 PCR Reagents & Consumables Market Background
  • 6.1.1. Introduction
  • 6.1.2. PCR Reagents & Consumables Market: Conclusions
  • 6.1.3. PCR Reagents & Consumables: Business Opportunities
  • 6.1.4. PCR Reagents & Consumables: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
• 6.2. 1.2 Global COVID-19 Pandemic Mitigation: PCR Reagents & Consumables Market - 2020-2024
  • 6.2.1. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 6.2.2. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

7. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024

• 7.1. COVID-19 Nose & Mouth Swabs Market Background
  • 7.1.1. Introduction and Findings
  • 7.1.2. Nose & Mouth Swabs: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
• 7.2. Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Market - 2020-2024
  • 7.2.1. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 7.2.2. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

8. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024

• 8.1. COVID-19 Self-collection PCR Test Kits Market Background
  • 8.1.1. Saliva Tests
• 8.2. COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Market - 2020-2024
  • 8.2.1. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 8.2.2. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

9. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024

• 9.1. COVID-19 Serologic Test Kits Market Background
  • 9.1.1. Introduction and Findings
  • 9.1.2. FDA Statement Related to the Status of Serological (Antibody) Tests
  • 9.1.3. Coronavirus Antibody Test Kits
  • 9.1.4. Serologic Test Kits Market: Conclusions
  • 9.1.5. Serologic Test Kits: Business Opportunities
  • 9.1.6. Serologic Test Kits: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
  • 9.1.7. Key Vendors
• 9.2. Global COVID-19 Pandemic Mitigation: Serologic Test Kits Market - 2020-2024
  • 9.2.1. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 9.2.2. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

10. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024

• 10.1. COVID-19 Standoff Thermometry Market Background
  • 10.1.1. Introduction and Findings
  • 10.1.2. Standoff Thermometry Market: Conclusions
  • 10.1.3. Standoff Thermometry: Business Opportunities
  • 10.1.4. Key Vendors
• 10.2. Global COVID-19 Pandemic Mitigation: Standoff Thermometry Market - 2020-2024
  • 10.2.1. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 10.2.2. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

11. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

• 11.1. COVID-19 X-Ray Procedures Market Background
  • 11.1.1. Introduction and Findings
  • 11.1.2. X-Ray Procedures Market: Conclusions
  • 11.1.3. Key Vendors
• 11.2. Global COVID-19 Pandemic Mitigation: X-Ray Procedures Market - 2020-2024
  • 11.2.1. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 11.2.2. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

12. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

• 12.1. COVID-19 CT Procedures Market Background
  • 12.1.1. Introduction and Findings
  • 12.1.2. CT Procedures Market: Conclusions
  • 12.1.3. CT Procedures: Business Opportunities
  • 12.1.4. Key Vendors
• 12.2. Global COVID-19 Pandemic Mitigation: CT Procedures Market - 2020-2024
  • 12.2.1. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 12.2.2. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

13. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

• 13.1. COVID-19 Ultrasound Procedures Market Background
  • 13.1.1. Introduction and Findings
  • 13.1.2. FDA Approved " EMT & Field" Smartphone-Tablet Based Coronavirus Chest Ultrasound
  • 13.1.3. COVID-19 Chest Ultrasound Diagnostics
  • 13.1.4. Ultrasound Procedures Market: Conclusions
  • 13.1.5. Ultrasound Procedures: Business Opportunities
  • 13.1.6. Key Vendors
• 13.2. Global COVID-19 Pandemic Mitigation: Ultrasound Procedures Market - 2020-2024
  • 13.2.1. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 13.2.2. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

14. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024

• 14.1. COVID-19 FDG-PET/CT Procedures & Wastewater Testing Market Background
  • 14.1.1. Introduction and Findings
  • 14.1.2. FDG-PET/CT Procedures
  • 14.1.3. COVID-19 Wastewater Testing
  • 14.1.4. FDG-PET/CT Procedures & Wastewater Testing Market: Conclusions
  • 14.1.5. FDG-PET/CT Procedures & Wastewater Testing: Business Opportunities
  • 14.1.6. Key Vendors
• 14.2. Global COVID-19 Pandemic Mitigation: FDG-PET/CT Procedures & Wastewater Testing Market - 2020-2024
  • 14.2.1. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 14.2.2. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

15. PACS & Teleradiology COVID-19 Pandemic Mitigation Market - 2020-2024

• 15.1. PACS & Teleradiology Market Background
  • 15.1.1. Introduction and Findings
  • 15.1.2. The FDA PACS & Teleradiography COVID-19 Pandemic Policy
  • 15.1.3. PACS & Teleradiology Market: Conclusions
  • 15.1.4. PACS & Teleradiology: Business Opportunities
  • 15.1.5. Key Vendors
• 15.2. Global COVID-19 Pandemic Mitigation: PACS & TeleradiologyMarket - 2020-2024
  • 15.2.1. PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 15.2.2. PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

16. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024

• 16.1. Pandemic PPE Gowns Market Background
  • 16.1.1. Introduction and Findings
  • 16.1.2. PPE Gowns Market: Conclusions
  • 16.1.3. PPE Gowns: Business Opportunities
• 16.2. Global COVID-19 Pandemic Mitigation: PPE Gowns Market - 2020-2024
  • 16.2.1. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 16.2.2. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

17. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024

• 17.1. COVID-19 Gloves Market Background
  • 17.1.1. Introduction and Findings
  • 17.1.2. Gloves Market: Conclusions
  • 17.1.3. Gloves: Business Opportunities
• 17.2. Global COVID-19 Pandemic Mitigation: Gloves Market - 2020-2024
  • 17.2.1. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 17.2.2. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

18. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024

• 18.1. Medical Face Masks Market Background
  • 18.1.1. Introduction and Findings
  • 18.1.2. N95 Masks Vs. Surgical Mask
  • 18.1.3. Face Masks Precautions
  • 18.1.4. Face Masks Market: Conclusions
  • 18.1.5. Face Masks: Business Opportunities
  • 18.1.6. Key Vendors
• 18.2. Global COVID-19 Pandemic Mitigation: Face Masks Market - 2020-2024
  • 18.2.1. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 18.2.2. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

19. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024

• 19.1. Medical Face Shields Market Background
  • 19.1.1. Introduction and Findings
  • 19.1.2. Face Shields Standards
• 19.2. Global COVID-19 Pandemic Mitigation: Medical Face Shields Market - 2020-2024
  • 19.2.1. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 19.2.2. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

20. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024

• 20.1. Pandemic Eye Protection Market Background
  • 20.1.1. Introduction and Findings
  • 20.1.2. Key Vendors
• 20.2. Global COVID-19 Pandemic Mitigation: Eye Protection Market - 2020-2024
  • 20.2.1. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 20.2.2. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

21. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

• 21.1. Global COVID-19 Pandemic Mitigation: PPE Sterilization: Systems & Consumables Market - 2020-2024
  • 21.1.1. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 21.1.2. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

22. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024

• 22.1. Hand & Surface Sanitizers Market Background
• 22.2. Global COVID-19 Pandemic Mitigation: Hand & Surface Sanitizers Market - 2020-2024
  • 22.2.1. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 22.2.2. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

23. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024

• 23.1. Decontamination Market Background
  • 23.1.1. Introduction
  • 23.1.2. Definitions
  • 23.1.3. Timing and Location Of Cleaning And Disinfection Of Surfaces
  • 23.1.4. Hard (Non-porous) Surfaces
  • 23.1.5. Soft (Porous) Surfaces
  • 23.1.6. Electronics
  • 23.1.7. Linens, Clothing, and Other Items That Go in the Laundry
  • 23.1.8. Risk of Exposure
  • 23.1.9. Considerations for Employers
  • 23.1.10. Decontamination Market: Conclusions
• 23.2. Global COVID-19 Pandemic Mitigation: Decontamination Market - 2020-2024
  • 23.2.1. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 23.2.2. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

24. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024

• 24.1. Global COVID-19 Pandemic Mitigation: Other Personal Protection Gear Market - 2020-2024
  • 24.1.1. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 24.1.2. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

25. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024

• 25.1. Pandemic AI, Big Data & Deep Learning Market Background
  • 25.1.1. Introduction and Findings
  • 25.1.2. AI Based Early Warnings and Alerts
  • 25.1.3. Tracking and Prediction
  • 25.1.4. Data Dashboards
  • 25.1.5. Diagnosis and Prognosis
  • 25.1.6. COVID-19 Treatments Optimization
  • 25.1.7. COVID-19 Pandemic Social Control
  • 25.1.8. Pandemic Outbreak Forecasting
  • 25.1.9. AI, Big-Data and Deep Learning Assisted CT Imaging
  • 25.1.10. AI, Big-Data and Deep-Learning Assisted COVID-19 Treatment
  • 25.1.11. COVID-19: AI Assisted X-rays Imaging
  • 25.1.12. COVID-19 AI, Big Data & Deep Learning
  • 25.1.13. AI Assisted Pandemic Symptoms Analysis
  • 25.1.14. AI, Big Data & Deep Learning Market: Conclusions
  • 25.1.15. AI, Big Data & Deep Learning: Business Opportunities
  • 25.1.16. Key Vendors
• 25.2. Global COVID-19 Pandemic Mitigation: AI, Big Data & Deep Learning Market - 2020-2024
  • 25.2.1. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 25.2.2. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

26. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024

• 26.1. Pandemic Homecare IT Market Background
  • 26.1.1. Introduction and Findings
  • 26.1.2. Homecare IT Market: Conclusions
  • 26.1.3. Homecare IT: Business Opportunities
  • 26.1.4. Key Vendors
• 26.2. Global COVID-19 Pandemic Mitigation: Homecare IT Market - 2020-2024
  • 26.2.1. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 26.2.2. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

27. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024

• 27.1. Pandemic Geo-Surveillance Systems & Services Market Background
  • 27.1.1. Introduction and Findings
  • 27.1.2. MIT "Private Kit"
  • 27.1.3. The UK NHS COVID-19 App
  • 27.1.4. Companies Making Cell Location Tracking Technology
• 27.2. Global COVID-19 Pandemic Mitigation: Geo-Surveillance Systems & Services Market - 2020-2024
  • 27.2.1. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 27.2.2. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

28. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024

• 28.1. Pandemic E-Health Market Background
  • 28.1.1. Introduction and Findings
  • 28.1.2. E-Health Market: Conclusions
  • 28.1.3. E-Health: Business Opportunities
  • 28.1.4. Key Vendors
• 28.2. Global COVID-19 Pandemic Mitigation: E-Health Market - 2020-2024
  • 28.2.1. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 28.2.2. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

29. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024

• 29.1. Pandemic Blockchain Technologies Market Background
  • 29.1.1. Introduction and Findings
  • 29.1.2. Blockchain in Healthcare
  • 29.1.3. Blockchain Applications
  • 29.1.4. Blockchain Technologies Market: Conclusions
  • 29.1.5. Blockchain Technologies: Business Opportunities
  • 29.1.6. Key Vendors
• 29.2. Global COVID-19 Pandemic Mitigation: Blockchain Technologies Market - 2020-2024
  • 29.2.1. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 29.2.2. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

30. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024

• 30.1. Other Pandemics ICT Market Background
  • 30.1.1. Introduction and Findings
  • 30.1.2. Other ICT Market: Conclusions
  • 30.1.3. Other ICT: Business Opportunities
  • 30.1.4. Vendors
• 30.2. Global COVID-19 Pandemic Mitigation: Other ICT Market - 2020-2024
  • 30.2.1. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 30.2.2. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

31. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

• 31.1. Non-Invasive Ventilators Market Background
  • 31.1.1. Introduction and Findings
  • 31.1.2. The U.S. HHS Procurement Contracts On Non-Invasive Ventilators With Ten Vendors
  • 31.1.3. Helmet-Based Non-invasive Ventilators
  • 31.1.4. Non-invasive Ventilators Market: Conclusions
  • 31.1.5. Business Opportunities
  • 31.1.6. Non-invasive Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
  • 31.1.7. Key Vendors
• 31.2. Global COVID-19 Pandemic Mitigation: Noninvasive Ventilators Market - 2020-2024
  • 31.2.1. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 31.2.2. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

32. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

• 32.1. Invasive Mechanical Ventilators Market Background
  • 32.1.1. Introduction and Findings
  • 32.1.2. Challenges of Traditional Mechanical Ventilation Devices
    • 32.1.2.1. Difficult To Expand Capacity And Limited Portability
    • 32.1.2.2. Complex and Time Consuming To Administer Care
    • 32.1.2.3. Difficult To Switch Between Therapies
  • 32.1.3. Invasive Mechanical Ventilators Market: Conclusions
  • 32.1.4. Invasive Mechanical Ventilators: Business Opportunities
  • 32.1.5. Invasive Mechanical Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
  • 32.1.6. Key Vendors
• 32.2. Global COVID-19 Pandemic Mitigation: Invasive Mechanical Ventilators Market - 2020-2024
  • 32.2.1. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 32.2.2. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

33. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

• 33.1. Next Generation Ventilators Market Background
  • 33.1.1. Introduction and Findings
  • 33.1.2. Next Generation Ventilators Market: Conclusions
  • 33.1.3. Next Generation Ventilators: Business Opportunities
  • 33.1.4. Next Generation Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
• 33.2. Global COVID-19 Pandemic Mitigation: Next Generation Ventilators Market - 2020-2024
  • 33.2.1. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 33.2.2. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

34. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024

• 34.1. COVID-19 Homecare "ICU" (Equipment, Software, Services) Market Background
  • 34.1.1. Introduction and Findings
  • 34.1.2. WHO Protocol For COVID-19 Homecare
  • 34.1.3. Homecare Market: Conclusions
  • 34.1.4. Homecare Business Opportunities
  • 34.1.5. Homecare: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution
  • 34.1.6. Key Vendors
• 34.2. Global COVID-19 Pandemic Mitigation: Homecare "ICU" (Equipment, Software, Services) Market - 2020-2024
  • 34.2.1. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 34.2.2. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B
• 34.3. Portable Ventilators Market Background
  • 34.3.1. Introduction and Findings
  • 34.3.2. Portable Ventilators Market: Conclusions
  • 34.3.3. Key Vendors
• 34.4. Global COVID-19 Pandemic Mitigation: Mobile Ventilators Market - 2020-2024
  • 34.4.1. Mobile Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 34.4.2. Mobile Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

35. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024

• 35.1. Surge Capacity Hospitals Market Background
  • 35.1.1. Introduction and Findings
  • 35.1.2. Surge Capacity Hospitals Market: Conclusions
• 35.2. Global COVID-19 Pandemic Mitigation: Surge Capacity Hospitals Market - 2020-2024
  • 35.2.1. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 35.2.2. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

36. Kidney Dialysis COVID-19 Pandemic Mitigation Market - 2020-2024

• 36.1. Kidney Dialysis Systems Market Background
  • 36.1.1. Introduction and Findings
  • 36.1.2. Kidney Dialysis Systems Market: Conclusions
  • 36.1.3. Kidney Dialysis Systems: Business Opportunities
  • 36.1.4. Key Vendors
• 36.2. Global COVID-19 Pandemic Mitigation: Kidney Dialysis Market - 2020-2024
  • 36.2.1. Kidney DialysisCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 36.2.2. Kidney DialysisCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

37. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

• 37.1. Extracorporeal Membrane Oxygenation Procedures Market Background
  • 37.1.1. Introduction and Findings
  • 37.1.2. The FDA Extracorporeal Membrane Oxygenation (ECMO) Policy
  • 37.1.3. Extracorporeal Membrane Oxygenation Procedures Market: Conclusions
  • 37.1.4. Extracorporeal Membrane Oxygenation Procedures: Business Opportunities
  • 37.1.5. Key Vendors
• 37.2. Global COVID-19 Pandemic Mitigation: Extracorporeal Membrane Oxygenation Procedures Market - 2020-2024
  • 37.2.1. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 37.2.2. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

38. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024

• 38.1. Other Intensive Care Modalities Market Background
  • 38.1.1. Introduction and Findings
  • 38.1.2. Other Intensive Care Modalities Market: Conclusions
• 38.2. Global COVID-19 Pandemic Mitigation: Other Intensive Care Modalities Market - 2020-2024
  • 38.2.1. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 38.2.2. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

39. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 39.1. PPE Gowns Manufacturing Plants Market Background
  • 39.1.1. Introduction and Findings
  • 39.1.2. Gowns Manufacturing Plants Market: Conclusions
  • 39.1.3. Gowns Manufacturing Plants: Business Opportunities
• 39.2. Global COVID-19 Pandemic Mitigation: Gowns Manufacturing Plants Market - 2020-2024
  • 39.2.1. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 39.2.2. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

40. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 40.1. Medical PPE Gloves Manufacturing Plants Market Background
  • 40.1.1. Introduction and Findings
  • 40.1.2. Medical PPE Gloves Manufacturing Plants Market: Conclusions
  • 40.1.3. Medical PPE Gloves Manufacturing Plants: Business Opportunities
• 40.2. Global COVID-19 Pandemic Mitigation: Gloves Manufacturing Plants Market - 2020-2024
  • 40.2.1. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 40.2.2. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

41. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 41.1. Face Masks Manufacturing Plants Market Background
  • 41.1.1. Introduction and Findings
  • 41.1.2. N95 Respirators Manufacturing
  • 41.1.3. Face Masks Manufacturing Plants Market: Conclusions
  • 41.1.4. Face Masks Manufacturing Plants: Business Opportunities
  • 41.1.5. Key Vendors
• 41.2. Global COVID-19 Pandemic Mitigation: Face Masks Manufacturing Plants Market - 2020-2024
  • 41.2.1. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 41.2.2. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

42. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 42.1. Face Shields Manufacturing Plants Market Background
  • 42.1.1. Introduction and Findings
• 42.2. Global COVID-19 Pandemic Mitigation: Face Shields Manufacturing Plants Market - 2020-2024
  • 42.2.1. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 42.2.2. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

43. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 43.1. Serologic Test Kits Manufacturing Plants Market Background
  • 43.1.1. Introduction and Findings
  • 43.1.2. Serologic Test Kits Manufacturing Plants Market: Conclusions
• 43.2. Global COVID-19 Pandemic Mitigation: Serologic Test Kits Manufacturing Plants Market - 2020-2024
  • 43.2.1. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 43.2.2. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

44. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 44.1. Melt-Blown PPE Fabric Manufacturing Plants Market Background
  • 44.1.1. Introduction and Findings
  • 44.1.2. Melt-Blown PPE Fabric. Manufacturing Plants Market: Conclusions
• 44.2. Global COVID-19 Pandemic Mitigation: Melt-Blown PPE Fabric Manufacturing Plants Market - 2020-2024
  • 44.2.1. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 44.2.2. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

45. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 45.1. Spun-Bond PPE Fabric Manufacturing Plants Market Background
  • 45.1.1. Introduction and Findings
  • 45.1.2. Spun-Bond PPE Fabric Manufacturing Plants Market: Conclusions
• 45.2. Global COVID-19 Pandemic Mitigation: Spun-Bond PPE Fabric Manufacturing Plants Market - 2020-2024
  • 45.2.1. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 45.2.2. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

46. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 46.1. Market Background
• 46.2. Global COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Manufacturing Plants Market - 2020-2024
  • 46.2.1. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 46.2.2. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

47. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 47.1. Ventilators Manufacturing Plants Market Background
  • 47.1.1. Introduction and Findings
  • 47.1.2. Ventilators Manufacturing Plants Market: Conclusions
• 47.2. Global COVID-19 Pandemic Mitigation: Ventilators Manufacturing Plants Market - 2020-2024
  • 47.2.1. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 47.2.2. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

48. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 48.1. Global COVID-19 Pandemic Mitigation: PCR Reagents Manufacturing Plants Market - 2020-2024
  • 48.1.1. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 48.1.2. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

49. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 49.1. Global COVID-19 Pandemic Mitigation: PCR Systems Manufacturing Plants Market - 2020-2024
  • 49.1.1. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 49.1.2. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

50. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 50.1. Nose & Mouth Swabs Manufacturing Plants Market Background
  • 50.1.1. Introduction and Findings
  • 50.1.2. Swabs Manufacturing Plants Market: Conclusions
  • 50.1.3. Swabs Manufacturing Plants: Business Opportunities
• 50.2. Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Manufacturing Plants Market - 2020-2024
  • 50.2.1. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 50.2.2. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

51. Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

• 51.1. Global COVID-19 Pandemic Mitigation: Medical Glass & Other Manufacturing Plants Market - 2020-2024
  • 51.1.1. Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 51.1.2. Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

52. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

• 52.1. Global COVID-19 Pandemic Mitigation: R&D Equipment & Consumables Market - 2020-2024
  • 52.1.1. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 52.1.2. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

53. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024

• 53.1. Medical Glass and Other Products & Services Market Background
  • 53.1.1. Medical Glass Introduction and Findings
  • 53.1.2. Medical Glass Market: Conclusions
  • 53.1.3. Key Medical Glass Vendors
• 53.2. Global COVID-19 Pandemic Mitigation: Medical Glass and Other Products & Services Market - 2020-2024
  • 53.2.1. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario A
  • 53.2.2. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024: Scenario B

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 3

VERTICAL MARKETS

1. Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024

• 1.1. Market Background
• 1.2. Global COVID-19 Pandemic Mitigation: Hospitals and Surge Hospitals Market - 2020-2024
  • 1.2.1. COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario A
  • 1.2.2. COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario B
  • 1.2.3. Hospitals and Surge Hospitals Market: Scenarios Comparison

2. Clinical Labs COVID-19 Pandemic Mitigation Market - 2020-2024

• 2.1. Market Background
• 2.2. Global COVID-19 Pandemic Mitigation: Clinical Labs Market - 2020-2024
  • 2.2.1. COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario A
  • 2.2.2. COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario B
  • 2.2.3. Clinical Labs Market: Scenarios Comparison

3. Clinics COVID-19 Pandemic Mitigation Market - 2020-2024

• 3.1. Market Background
• 3.2. Global COVID-19 Pandemic Mitigation: Clinics Market - 2020-2024
  • 3.2.1. COVID-19 Pandemic Mitigation Clinics Market: Scenario A
  • 3.2.2. COVID-19 Pandemic Mitigation Clinics Market: Scenario B
  • 3.2.3. Clinics Market: Scenarios Comparison

4. Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market - 2020-2024

• 4.1. Market Background
• 4.2. Global COVID-19 Pandemic Mitigation: Emergency Medical Services (EMS) Market - 2020-2024
  • 4.2.1. COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario A
  • 4.2.2. COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario B
  • 4.2.3. Emergency Medical Services Market: Scenarios Comparison

5. Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market - 2020-2024

• 5.1. Market Background
• 5.2. Global COVID-19 Pandemic Mitigation: Homecare & Nursing Homes Market - 2020-2024
  • 5.2.1. COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario A
  • 5.2.2. COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario B
  • 5.2.3. Homecare & Nursing Homes Market: Scenarios Comparison

6. Research Bodies COVID-19 Pandemic Mitigation Market - 2020-2024

• 6.1. Market Background
• 6.2. Global COVID-19 Pandemic Mitigation: Research Bodies Market - 2020-2024
  • 6.2.1. COVID-19 Pandemic Mitigation Research Bodies Market: Scenario A
  • 6.2.2. COVID-19 Pandemic Mitigation Research Bodies Market: Scenario B
  • 6.2.3. Research Bodies Market: Scenarios Comparison

REGIONAL MARKETS

7. North America COVID-19 Pandemic Mitigation Market - 2020-2024

• 7.1. North America Vertical Markets - 2020-2024
  • 7.1.1. North America COVID-19 Pandemic Mitigation Market: Scenario A
  • 7.1.2. North America COVID-19 Pandemic Mitigation Market: Scenario B
  • 7.1.3. Scenarios Comparison
• 7.2. North America COVID-19 Pandemic Mitigation Market by Revenue Source - 2020-2024
  • 7.2.1. North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
  • 7.2.2. North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

8. Europe COVID-19 Pandemic Mitigation Market - 2020-2024

• 8.1. Europe Vertical Markets - 2020-2024
  • 8.1.1. Europe COVID-19 Pandemic Mitigation Market: Scenario A
  • 8.1.2. Europe COVID-19 Pandemic Mitigation Market: Scenario B
  • 8.1.3. Scenarios Comparison
• 8.2. Europe COVID-19 Market by Revenue Source - 2020-2024
  • 8.2.1. Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
  • 8.2.2. Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

9. Asia-Pacific COVID-19 Pandemic Mitigation Market - 2020-2024

• 9.1. Asia-Pacific Vertical Markets - 2020-2024
  • 9.1.1. Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario A
  • 9.1.2. Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario B
  • 9.1.3. Scenarios Comparison
• 9.2. Asia-Pacific COVID-19 Market by Revenue Source - 2020-2024
  • 9.2.1. Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
  • 9.2.2. Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

10. MEA & Latin America COVID-19 Pandemic Mitigation Market - 2020-2024

• 10.1. MEA & Latin America Vertical Markets - 2020-2024
  • 10.1.1. MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario A
  • 10.1.2. MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario B
  • 10.1.3. Scenarios Comparison
• 10.2. MEA & Latin America COVID-19 Market by Revenue Source - 2020-2024
  • 10.2.1. MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
  • 10.2.2. MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

NATIONAL MARKETS

11. USA COVID-19 Pandemic Mitigation Market - 2020-2024

• 11.1. Market Background
• 11.2. USA COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

12. Canada COVID-19 Pandemic Mitigation Market - 2020-2024

• 12.1. Market Background
• 12.2. Canada COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

13. U.K. COVID-19 Pandemic Mitigation Market - 2020-2024

• 13.1. Market Background
• 13.2. U.K. COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

14. Germany COVID-19 Pandemic Mitigation Market - 2020-2024

• 14.1. Market Background
• 14.2. Germany COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

15. France COVID-19 Pandemic Mitigation Market - 2020-2024

• 15.1. Market Background
• 15.2. France COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

16. Italy COVID-19 Pandemic Mitigation Market - 2020-2024

• 16.1. Market Background
• 16.2. Italy COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

17. Rest of Europe COVID-19 Pandemic Mitigation Market - 2020-2024

18. India COVID-19 Pandemic Mitigation Market - 2020-2024

• 18.1. Market Background
• 18.2. India COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

19. China COVID-19 Pandemic Mitigation Market - 2020-2024

• 19.1. Market Background
• 19.2. China COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

20. South Korea COVID-19 Pandemic Mitigation Market - 2020-2024

• 20.1. Market Background
• 20.2. South Korea COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

21. Japan COVID-19 Pandemic Mitigation Market - 2020-2024

• 21.1. Market Background
• 21.2. Japan COVID-19 Pandemic Mitigation Market Scenarios- 2020-2024

22. Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market - 2020-2024

23. ROW COVID-19 Pandemic Mitigation Market - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 4

APPENDICES

1. Appendix 1: Differences & Similarities Between Common Flu and Coronavirus

• 1.1. Similarities:
• 1.2. Differences

2. Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel

• 2.1. Introduction
• 2.2. Conclusions
• 2.3. Findings Summary
• 2.4. Background
  • 2.4.1. Description of the Condition
  • 2.4.2. Description of the Intervention
  • 2.4.3. How the Intervention Might Work
  • 2.4.4. Why it Is Important To Do This Review
  • 2.4.5. Summary

3. Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection

• 3.1. Introduction
  • 3.1.1 Contingency Capacity Strategies
  • 3.1.2. Extended Use Of Eye Protection
  • 3.1.3. Crisis Capacity Strategies
  • 3.1.4. Selected Options for Reprocessing Eye Protection

4. Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns

• 4.1. Purpose
• 4.2. Conventional Capacity Strategies
• 4.3. Contingency Capacity Strategies
• 4.4. Crisis Capacity Strategies
• 4.5. Extended Use of Isolation Gowns
  • 4.5.1. Re-use of Cloth Isolation Gowns
  • 4.5.2. Prioritize Gowns
  • 4.5.3. When No Gowns Are Available

5. Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks

• 5.1. Purpose
• 5.2. Conventional Capacity Strategies
• 5.3. Contingency Capacity Strategies
• 5.4. When No Facemasks Are Available, Options Include

6. Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

7. Appendix 7: CDC Adult Vaccine Price List

• 7.1. CDC Vaccine 2020-2021 Price List
• 7.2. CDC Influenza Vaccine 2020-2021 Price List

8. Appendix 8: The CDC COVID-19 Bio-Safety Guidelines

• 8.1. The CDC Safety Practices for Critical Infrastructure Workers Exposed to a Person with Suspected or Confirmed COVID-19
• 8.2. Use of Cloth Face Coverings
• 8.3. The Emergency Medical Services Guidance
• 8.4. Recommendations for 911 PSAPs
  • 8.4.1. Modified Caller Queries
• 8.5. EMS Clinicians and Medical First Responders
  • 8.5.1. Patient assessment
• 8.6. Recommended Personal Protective Equipment
• 8.7. Precautions for Aerosol-Generating Procedures
• 8.8. EMS Transport of a PUI or Patient with Confirmed COVID-19 to a Healthcare Facility
• 8.9. Documentation Of Patient Care
• 8.10. Cleaning EMS Transport Vehicles after Transporting a PUI or Patient with Confirmed COVID-19
• 8.11. Measures by EMS Clinicians After Caring for a PUI or Patient with Confirmed COVID-19
• 8.12. EMS Employer Responsibilities

9. Appendix 9: The 2020 Global Desperation to Protect Medical Workers

10. Appendix 10: Disinfection Procedures for COVID-19

• 10.1. Disinfection for Floor and Walls
• 10.2. Disinfection of Object Surfaces
• 10.3. Air Disinfection
• 10.4. Disposal of Fecal Matter and Sewage
• 10.5. Disposal Procedures for Spills of COVID-19 Patient Blood/Fluids

11. Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020

• 11.1. Public Health and Social Services Emergency Fund - March 2020
• 11.2. For Advance Construction, Manufacture, And Purchase Of Vaccines And Therapeutic Delivery
• 11.3. Telehealth, Poison Control Centers, And The Ryan White HIV/AIDS Program
• 11.4. National Institutes of Health
• 11.5. Substance Abuse and Mental Health Services Administration
• 11.6. Administration for Children and Families
• 11.7. Veterans Health Administration

12. Appendix 12: European Preparedness Against Emerging Epidemics

13. Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19

• 13.1. Introduction
• 13.2. Diagnostic Tests
  • 13.1.1. IVD Tests
  • 13.1.2. LDT Tests
  • 13.1.3. How are IVD Tests Regulated?
  • 13.1.4. How are LDTs Regulated?
  • 13.1.5. What is CLIA and How Is It Involved in LDT Regulation?
  • 13.1.6. How are IVDs Regulated by the FDA During an Emergency Such as the Outbreak of COVID-19?
  • 13.1.7. How Does the Emergency Use Authority Apply to LDTs if They Are Generally Exempted from Premarket Requirements?
  • 13.1.8. How Does the CDC's COVID-19 Diagnostic Test Work?
  • 13.1.9. What Type of IVD is the CDC's Test and Who May Carry it Out?
  • 13.1.10. What Is the Role of the Commercial Manufacturer IDT in the Development and Distribution of the CDC's Test Kit?
  • 13.1.11. What Quality Problems Did the CDC's Test Experience on Rollout to the State and Local Public Health Laboratories?
  • 13.1.12. What Steps did the FDA Take to Expand Testing Capacity in Response to the Problems with the CDC's Test?

14. Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

15. Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)

16. Appendix 16: Comparing Clinical COVID-19 Data by Nation

• 16.1. Introduction
• 16.2. Counting Deaths Protocols
• 16.3. National Death Rates
• 16.4. National Political Factors
• 16.5. National Testing Protocols
• 16.6. Conclusions: Comparisons are Difficult

17. Appendix 17: Home Healthcare IT

• 17.1. Introduction
• 17.2. Online Bots
• 17.3. Home Telehealth
• 17.4. Telemedicine Billing
• 17.5. Commercial Insurance

18. Appendix 18: The Difference between PCR and Antibody Tests

19. Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021

• 19.1. Introduction
• 19.2. Economic Effects
• 19.3. USA
• 19.4. Europe
• 19.5. The UK
• 19.6. Japan
• 19.7. China
• 19.8. The IMF
• 19.9. The World Bank
• 19.10 Emerging Markets
• 19.11 Other Sectors

20. Appendix 20: COVID-19 Tests

• 20.1. COVID-19 Tests Sensitivity and Specificity
• 20.2. RT-PCR tests
• 20.3. Antibody Tests
• 20.4. Other Diagnostic Options
• 20.5. Procurement of Test Kits and Consumables
• 20.6. Annex A: Test Kit Options from WHO Diagnostics Consortium

21. Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region

22. Appendix 22: Abbreviations

23. Appendix 23: Glossary

24. Appendix 24: Bibliography

25. Research Methodology

• 25.1. Scope
• 25.2. Research Methodology

26. Disclaimer & Copyright

관련자료